XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2024
Cash flows from operating activities:          
Net income $ 92,854,000 $ 98,327,000 $ 407,182,000 $ 217,010,000  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization of intangible assets     480,405,000 630,275,000  
Share-based compensation expense     82,919,000 113,312,000  
Pension expense     10,194,000 9,579,000  
Amortization of debt discount and issuance costs     16,334,000 19,587,000  
Write-off of right of use assets     1,431,000 15,241,000  
Adjustment to gain on AMC Divestiture 0 0 4,175,000 0  
Loss on extinguishment of debt 0 10,803,000 0 10,803,000  
Loss on sale and write down of property and equipment, net     728,000 1,715,000  
Deferred taxes     (91,771,000) (249,174,000)  
Share in net (income) loss of equity investees (1,644,000) 835,000 (3,637,000) 19,013,000  
Changes in derivative instruments 9,836,000 (16,671,000) (10,778,000) 3,551,000  
Changes in operating assets and liabilities:          
Accounts receivable     111,909,000 51,487,000  
Contract assets     (96,101,000) (71,486,000)  
Prepaid expenses and other current assets     37,177,000 4,717,000  
Income taxes     (184,149,000) 75,676,000  
Accounts payable and accrued liabilities     (81,308,000) (72,887,000)  
Deferred revenue     10,960,000 14,338,000  
Other assets     (7,582,000) 5,868,000  
Operating lease assets and liabilities, net     (15,661,000) (16,154,000)  
Net cash provided by operating activities     672,427,000 782,471,000  
Cash flows from investing activities:          
Additions of property and equipment     (108,997,000) (119,316,000)  
Purchase of Micro Focus, net of cash acquired     0 (9,272,000)  
Settlement of derivative instruments     (10,380,000) 0  
Adjustment to proceeds from AMC Divestiture     (11,686,000) 0  
Proceeds from interest on derivative instruments     5,166,000 4,456,000  
Other investing activities     6,474,000 (468,000)  
Net cash used in investing activities     (119,423,000) (124,600,000)  
Cash flows from financing activities:          
Proceeds from issuance of Common Shares from exercise of stock options and ESPP     25,925,000 57,027,000  
Repayment of long-term debt and Revolver     (26,888,000) (559,389,000)  
Net change in transition services agreement obligation     (15,277,000) 0  
Debt issuance costs     (1,066,000) (2,792,000)  
Repurchase of Common Shares     (267,969,000) 0  
Purchase of treasury stock   0 (70,159,000) (53,085,000)  
Payments of dividends to shareholders (67,900,000) (67,300,000) (205,335,000) (200,672,000)  
Other financing activities     0 (1,447,000)  
Net cash used in financing activities     (560,769,000) (760,358,000)  
Foreign exchange gain (loss) on cash held in foreign currencies     4,866,000 (3,982,000)  
Decrease in cash, cash equivalents and restricted cash during the period     (2,899,000) (106,469,000)  
Cash, cash equivalents and restricted cash at beginning of the period     1,282,793,000 1,233,952,000 $ 1,233,952,000
Cash, cash equivalents and restricted cash at end of the period 1,279,894,000 1,127,483,000 1,279,894,000 1,127,483,000 1,282,793,000
Reconciliation of cash, cash equivalents and restricted cash:          
Cash and cash equivalents 1,277,950,000 1,125,323,000 1,277,950,000 1,125,323,000 1,280,662,000
Restricted cash [1] 1,944,000 2,160,000 1,944,000 2,160,000  
Total cash, cash equivalents and restricted cash $ 1,279,894,000 $ 1,127,483,000 $ 1,279,894,000 $ 1,127,483,000 $ 1,282,793,000
[1] Restricted cash is classified under the Prepaid expenses and other current assets and Other assets line items on the Condensed Consolidated Balance Sheets (Note 7).